Published at Jan 29, 2025 6:43 PM by manilatimes.net neutral neutral BioPorto A/S appoints new interim Chairman of the Board **media[527539]** THOXFBVNRYBVNKF0JJM.L Read more →
Published at Jan 6, 2025 6:28 PM by manilatimes.net neutral neutral Preliminary Financial Figures for the 2024 Fiscal Year **media[507276]** THOXF0JJM.L Read more →
Published at Dec 16, 2024 7:10 PM by manilatimes.net positive positive BioPorto commences process to appoint new Chair of the Board of Directors **media[493852]** THOXF0JJM.L Read more →
Published at Nov 14, 2024 9:10 AM by manilatimes.net positive positive BioPorto Announces Interim Results and Business Update for the Third Quarter and Nine Months of Fiscal 2024 **media[465692]** THOXF0JJM.L Read more →
Published at Nov 12, 2024 10:10 AM by manilatimes.net positive positive BioPorto A/S to Host Third Quarter 2024 Earnings Webcast **media[462950]** THOXF0JJM.L Read more →
Published at Nov 8, 2024 5:29 PM by manilatimes.net positive positive BioPorto Sponsors Exhibits to Showcase Launch of ProNephro AKI in the U.S. and Ongoing Marketing of The NGAL Test to Clinicians at Major Healthcare Conferences **media[460518]** THOXF0JJM.L Read more →
Published at Nov 4, 2024 7:09 PM by manilatimes.net positive positive Grant of Warrants **media[455890]** THOXF0JJM.L Read more →
Published at Oct 22, 2024 8:23 AM by manilatimes.net positive positive BioPorto is proud to have Nine of the top-ten best US Children's hospitals as customers of NGAL **media[443002]** THOXF0JJM.L Read more →
Published at Oct 21, 2024 5:15 PM by globenewswire.com neutral neutral BioPorto A/S annoncerer ændringer til den amerikanske kommercielle organisation 21. oktober 2024Pressemeddelelse BioPorto A/S annoncerer ændringer til den amerikanske kommercielle organisation KØBENHAVN, DANMARK og BOSTON, MA, USA,... THOXF0JJM.L Read more →
Published at Oct 10, 2024 4:17 PM by globenewswire.com positive positive BioPorto Announces Appointment of National Principal Investigator and Selection of CRO for Upcoming USA ICU Adult AKI Clinical Study October 10, 2024 News Release BioPorto Announces Appointment of National Principal Investigator and Selection of CRO for... THOXF0JJM.L Read more →